Aprinoia Therapeutics Company

Biotechnology, Neuorscience

Total Funding: 57530000.0
Headquarters: Boston, Massachusetts, United States
Funding Status: Late Stage Venture
Estimated Revenue: $1M to $10M
Last Funding Type: Series C
Last Funding Date: 2021-12-28
Investors Number: 8.0
Founded Date: 2015-05-20
Industry: Neuroimaging